Clinical Trial Update: Study to Assess the Effects of FX006 on Blood Glucose in Patients With OA of the Knee and Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FX006 effects on blood glucose in patients with osteoarthritis of the knee and type 2 diabetes; study completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee
• Type 2 Diabetes Mellitus

Drugs mentioned

• FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee, Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2018-01-26